342 related articles for article (PubMed ID: 28273828)
1. Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Du K; Liu M; Pan Y; Zhong X; Wei M
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273828
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
[TBL] [Abstract][Full Text] [Related]
3. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
[TBL] [Abstract][Full Text] [Related]
5. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
Hare DJ; Faux NG; Roberts BR; Volitakis I; Martins RN; Bush AI
Metallomics; 2016 Jun; 8(6):628-32. PubMed ID: 26962965
[TBL] [Abstract][Full Text] [Related]
6. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
[TBL] [Abstract][Full Text] [Related]
7. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
9. Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
Du K; Liu MY; Pan YZ; Zhong X; Wei MJ
Neurosci Lett; 2018 Feb; 665():92-98. PubMed ID: 29191695
[TBL] [Abstract][Full Text] [Related]
10. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
[TBL] [Abstract][Full Text] [Related]
11. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Song YN; Wang P; Xu W; Li JQ; Cao XP; Yu JT; Tan L
J Alzheimers Dis; 2018; 66(2):497-515. PubMed ID: 30320579
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
14. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
[TBL] [Abstract][Full Text] [Related]
17. Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study.
Zhu CJ; Jiang GX; Chen JM; Zhou ZM; Cheng Q
Brain Res Bull; 2018 Mar; 137():301-305. PubMed ID: 29325993
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status and body composition by bioelectrical impedance vector analysis: A cross sectional study in mild cognitive impairment and Alzheimer's disease.
Cova I; Pomati S; Maggiore L; Forcella M; Cucumo V; Ghiretti R; Grande G; Muzio F; Mariani C
PLoS One; 2017; 12(2):e0171331. PubMed ID: 28187148
[TBL] [Abstract][Full Text] [Related]
19. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
Kim YS; Lee KJ; Kim H
Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
[TBL] [Abstract][Full Text] [Related]
20. Blood fatty acids in Alzheimer's disease and mild cognitive impairment: A meta-analysis and systematic review.
Hosseini M; Poljak A; Braidy N; Crawford J; Sachdev P
Ageing Res Rev; 2020 Jul; 60():101043. PubMed ID: 32194194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
